György Krasznay

Title: György Krasznay: Innovator in Pharmaceutical Chemistry

Introduction

György Krasznay is a notable inventor based in Budapest, Hungary. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of processes for the preparation of important compounds.

Latest Patents

Krasznay holds a patent for a process related to the preparation of olanzapine. This compound, known chemically as 2-methyl-4-(4-methylpiperazin-1-yl)-10H-thieno-[2,3-b][1,5]benzodiazepine, is crucial in the treatment of various psychiatric disorders. The patented process involves reacting 4-amino-2-methyl-10H-thieno[2,3-b][1/5]benzodiazepine hydrochloride with N-methylpiperazine in a specific organic solvent mixture of toluene and 1,3-dimethyl-2-imidazolidinone. Additionally, the invention includes a new form of olanzapine, specifically the dihydrochloride trihydrate, along with its preparation and pharmaceutical compositions.

Career Highlights

Krasznay is associated with Egis Gyógyszergyár Nyilvánosan Mukodo Részvénytársaság, a prominent pharmaceutical company in Hungary. His work has been instrumental in advancing the company's research and development efforts in the pharmaceutical sector.

Collaborations

Throughout his career, Krasznay has collaborated with notable colleagues, including Györgyi Kovanyine Lax and Gábor Nemeth. These partnerships have contributed to the successful development of innovative pharmaceutical solutions.

Conclusion

György Krasznay's contributions to pharmaceutical chemistry, particularly through his patent for the preparation of olanzapine, highlight his role as an influential inventor in the industry. His work continues to impact the field positively.